Get the Stockscreener App
4.50
5.26%
-0.25
After Hours:
4.50
Pulmatrix Inc stock is traded at $4.50, with a volume of 7,437.
It is down -5.26% in the last 24 hours and down -6.50% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.75
Open:
$4.85
24h Volume:
7,437
Relative Volume:
0.69
Market Cap:
$17.35M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-1.8672
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-7.33%
1M Performance:
-6.50%
6M Performance:
-30.56%
1Y Performance:
-33.04%
1-Day Range:
$4.50
$4.85
1-Week Range:
$4.50
$4.98
52-Week Range:
$4.33
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.50 | 17.35M | 11.68M | -8.85M | -14.61M | -2.41 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Can Pulmatrix Inc. stock outperform in 2025 bull marketShare Buyback & Stock Portfolio Risk Management - newser.com
Is Pulmatrix Inc. stock a smart buy before Fed meeting2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Will Pulmatrix Inc. (2PU) stock see valuation expansionQuarterly Market Review & Long-Term Growth Portfolio Plans - newser.com
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Is Pulmatrix Inc. (2PU) stock undervalued by metricsJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Will Pulmatrix Inc. stock go up soonGap Up & High Yield Stock Recommendations - newser.com
What recovery options are there for Pulmatrix Inc.2025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
How Pulmatrix Inc. stock trades during market volatilityMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Can Pulmatrix Inc. (2PU) stock double in coming yearsChart Signals & Consistent Profit Alerts - newser.com
Using RSI to spot recovery in Pulmatrix Inc.Weekly Trend Report & Entry and Exit Point Strategies - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionTrend Reversal & Reliable Entry Point Alerts - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Is Pulmatrix Inc a good long term investmentHigh Beta Stocks & Your Roadmap to 10x Returns Starts Here - earlytimes.in
Analyzing Pulmatrix Inc. with risk reward ratio chartsTrade Signal Summary & Short-Term High Return Strategies - newser.com
Is Pulmatrix Inc. stock gaining market shareJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Will Pulmatrix Inc. stock recover after recent dropQuarterly Portfolio Review & Fast Gain Stock Tips - newser.com
Trend analysis for Pulmatrix Inc. this weekPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Is Pulmatrix Inc. stock attractive for long term wealth buildingTrade Risk Report & Weekly Top Gainers Trade List - newser.com
Is it time to cut losses on Pulmatrix Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Will Pulmatrix Inc. stock deliver consistent dividends2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
How Pulmatrix Inc. (2PU) stock responds to bond market2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Is Pulmatrix Inc. stock a good choice for value investorsEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
Will Pulmatrix Inc. stock return to pre crisis levels2025 Year in Review & Long-Term Safe Return Strategies - Fundação Cultural do Pará
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stock2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.08%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):